## LMT: Lockheed Martin Corporation - XLI: Industrials

### Executive Summary

No thesis match: MRS_20 1.2% below STRENGTH zone (4.0-10.0%); PEG 1.54 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($455.56)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 3, Bearish: 0)

**1. DOL Eyes Amicus Filing While States, Industry Back Lockheed Martin in PRT Case**
- Source: plansponsor | 20251211T214129 | Neutral | Relevance: 100%
-  The Department of Labor (DOL) is considering filing an amicus brief in support of Lockheed Martin in a high-profile pension risk transfer (PRT) case, signaling a potential shift in its stance on ERISA litigation. This move follows the solicitor general's recent recommendations to the Supreme Court to side with employers in other ERISA cases. Meanwhile, several states and employer advocacy groups have already filed briefs supporting Lockheed Martin, arguing that retirees lack standing to sue as they have suffered no harm from these transactions.

**2. Lockheed Martin Corp -On Dec 5 Entered Into New 364-Day Revolving Credit Agreement - SEC Filing**
- Source: TradingView | 20251209T224620 | Somewhat-Bullish | Relevance: 99%
-  Lockheed Martin Corp (LMT) announced it has entered into a new 364-day revolving credit agreement on December 5. This agreement includes a $3.0 billion unsecured revolving credit facility and is set to mature on December 4, 2026, with an option for a term loan.

**3. Hensoldt partners with Lockheed Martin for German naval systems**
- Source: Investing.com | 20251209T090855 | Bullish | Relevance: 99%
- Hensoldt will act as Lockheed Martin Canadaâ€™s German-based contractor to integrate the CMS 330 combat management system into German naval platforms, with work commencing in early 2026. This system aims to boost the capabilities of German naval vessels by enhancing real-time situational awareness and coordinated decision-making. The partnership underscores a strategic collaboration to improve operational effectiveness through advanced technological integration.

**4. Hensoldt partners with Lockheed Martin for German naval systems By Investing.com**
- Source: Investing.com Canada | 20251209T090332 | Bullish | Relevance: 99%
- Hensoldt has partnered with Lockheed Martin Canada to integrate the CMS 330 combat management system into German naval platforms. This integration work is set to begin in early 2026 and aims to enhance the capabilities of German naval vessels by providing real-time situational awareness and improving operational effectiveness. The CMS 330 system connects shipboard sensors, weapons, and communications for coordinated decision-making.

**5. Lockheed Teams With Hadrian for Faster Missile Output**
- Source: The Defense Post | 20251210T161038 | Bullish | Relevance: 98%
-  Lockheed Martin has partnered with Hadrian to accelerate the manufacture of key missile components, aiming to enhance US defense production resilience and scalability. Hadrian will deploy its factory-as-a-service model, including flexible machining and inspection cells, at a Lockheed Martin Missiles and Fire Control site. This collaboration is intended to rapidly increase production of parts for systems like PAC-3 MSE and THAAD, enabling Lockheed Martin to meet rising demand more quickly.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 2 ($0.00M) |
| Sells | 7 ($1.59M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 43.8% |
| Smart Money | **BEARISH** |
| Net Flow | 0.0% |
| Buying/Selling | 3 / 6 |

**Top Holders:**
- State Street Corpora: 14.8% (-1.0%)
- Vanguard Group Inc: 9.2% (-1.9%)
- Blackrock Inc.: 7.3% (-2.4%)
- Charles Schwab Inves: 3.7% (+8.6%)
- Morgan Stanley: 2.2% (-2.1%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Momentum building: MRS_20 improving +4.4% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.54 elevated, pricing in significant growth expectations. Forward P/E 16.3x attractive for 31% earnings growth. Quality metrics strong (ROE 63%). Balance sheet: $3.3B free cash flow. Insider selling cluster ($1.6M in 90 days), potential headwind. Institutional flow bearish (6 selling vs 3 buying).

| Metric | Value |
|--------|-------|
| Market Cap | $110.9B |
| Beta | 0.24 |
| 52W Range | $410.11 - $516.00 |
| Short Interest | 1.7% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.54 |
| Forward P/E | 16.3 |
| Current P/E | 21.4 |
| YoY Growth | 31.2% |
| EPS Direction | STABLE |

### Technicals

MRS_20 strengthening from -3.2% to 1.2% (+4.4% in 5 days), confirming momentum buildup. Below STRENGTH zone by 2.8pp (needs >4.0% for momentum thesis). MRS_5 at 2.0% confirms short-term momentum alignment. AM_20 at 3.5% shows strong absolute momentum above own 20MA. MACD histogram positive (3.40), confirming momentum. RSI neutral at 58.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 1.23% (CS: 53) | Neutral |
| RSI_14 | 58.5 | Neutral |
| MACD Histogram | 3.40 | Bullish |
| vs SMA20 | 1.034x | Above |
| vs SMA50 | 0.995x | Below |
| vs SMA200 | 1.022x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $474.88
- **Stop Loss:** $455.56 (4.1% risk)
- **Target:** $494.20 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 71
- **Position Value:** $33,716.48
- **Portfolio %:** 33.72%
- **Risk Dollars:** $1,380.00
- **Risk Per Trade:** 1.38%
- **Modifiers:** L1 115% | L2 120% | Combined 1.38x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX at low 8th percentile signals complacency, but decent breadth and positive yield curve support selective positioning. Focus on quality names with earnings visibility.*

### Earnings

**Next:** 2026-01-27 (Est: $6.64)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $6.35 | $6.95 | +9.4% |
| 2025Q2 | $6.47 | $1.46 | -77.4% |
| 2025Q1 | $6.32 | $7.28 | +15.1% |
| 2024Q4 | $6.62 | $7.71 | +16.5% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*